U2Bio Co., Ltd. (221800) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for U2Bio Co., Ltd. (221800:KRX), powered by AI.
- Current Price
- ₩18,610
- P/E Ratio
- -73.9
- Market Cap
- 210.1B
- Sector
- Healthcare
What is the U2Bio Co., Ltd. stock price forecast?
U2Bio Co., Ltd. is currently trading at ₩18,610. View real-time AI analysis on Alpha Lenz.
What is U2Bio Co., Ltd. insider trading activity?
View the latest insider trading data for U2Bio Co., Ltd. on Alpha Lenz.
What is U2Bio Co., Ltd.'s P/E ratio?
U2Bio Co., Ltd.'s P/E ratio is -73.9.
U2Bio Co., Ltd.
KRX · 221800“U2Bio Co., Ltd. trades at a P/E of -73.9 (undervalued) with modest ROE of -7.8%.”
Ask for details →Company Overview
U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers clinical laboratory test services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea.
Company Statistics
FY 2024Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“U2Bio Co., Ltd. trades at a P/E of -73.9 (undervalued) with modest ROE of -7.8%.”
Ask for details →Frequently Asked Questions
U2Bio Co., Ltd. (ticker: 221800) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). Market cap is $210.1B.
The current price is ₩18,610 with a P/E ratio of -73.95x and P/B of 6.1x.
ROE is -7.84% and operating margin is -11.69%. Annual revenue is $25.0B.